Madilyn Mason1, Marcelline R Harris, Joseph A Greer, Yun Jiang. 1. Author Affiliations: Department of Systems, Populations, and Leadership, University of Michigan School of Nursing, Ann Arbor (Ms Mason and Drs Harris and Jiang); Center for Psychiatric Oncology & Behavioral Sciences, Massachusetts General Hospital Cancer Center, Boston (Dr Greer).
Abstract
BACKGROUND: The rapid development and adoption of oral anticancer agents (OAAs) for cancer management have shifted patients' roles from recipient to owner of their care delivery, assuming their responsibilities for self-managing their OAA treatments at home, while the concept of oral anticancer agent self-management (OAA-SM) has not been well clarified and defined. OBJECTIVE: This study was to clarify the concept of OAA-SM and identify major components, influential factors, and consequences of OAA-SM, as well as propose a representative conceptual model of OAA-SM. METHODS: A literature review was conducted concerning the concept and application of OAA-SM. The Walker and Avant method for concept analysis was utilized to guide the examination of OAA-SM. RESULTS: OAA-SM is a multifaceted and dynamic process that requires continuous adaptation by patients as multiple self-management challenges can emerge throughout OAA treatments. The defining attributes of OAA-SM include OAA adherence, adverse-effect self-management, patient-provider communication, and OAA safe storage, handling, and administration practices. Oral anticancer agent-SM is potentially influenced by a variety of patient-related, OAA-related, and healthcare system factors. Effective OAA-SM is associated with better patient and healthcare outcomes. CONCLUSIONS: The clarification of the concept of OAA-SM and the identification of attributes of OAA-SM and their interrelationships contribute to the body of knowledge in OAA-SM. IMPLICATIONS FOR PRACTICE: This concept analysis provides the foundation to increase healthcare providers' understanding of patients' needs for OAA-SM support and guides the development of patient-centered interventions to empower and engage patients and their families in effective OAA-SM, and improve patients' quality of life and care.
BACKGROUND: The rapid development and adoption of oral anticancer agents (OAAs) for cancer management have shifted patients' roles from recipient to owner of their care delivery, assuming their responsibilities for self-managing their OAA treatments at home, while the concept of oral anticancer agent self-management (OAA-SM) has not been well clarified and defined. OBJECTIVE: This study was to clarify the concept of OAA-SM and identify major components, influential factors, and consequences of OAA-SM, as well as propose a representative conceptual model of OAA-SM. METHODS: A literature review was conducted concerning the concept and application of OAA-SM. The Walker and Avant method for concept analysis was utilized to guide the examination of OAA-SM. RESULTS: OAA-SM is a multifaceted and dynamic process that requires continuous adaptation by patients as multiple self-management challenges can emerge throughout OAA treatments. The defining attributes of OAA-SM include OAA adherence, adverse-effect self-management, patient-provider communication, and OAA safe storage, handling, and administration practices. Oral anticancer agent-SM is potentially influenced by a variety of patient-related, OAA-related, and healthcare system factors. Effective OAA-SM is associated with better patient and healthcare outcomes. CONCLUSIONS: The clarification of the concept of OAA-SM and the identification of attributes of OAA-SM and their interrelationships contribute to the body of knowledge in OAA-SM. IMPLICATIONS FOR PRACTICE: This concept analysis provides the foundation to increase healthcare providers' understanding of patients' needs for OAA-SM support and guides the development of patient-centered interventions to empower and engage patients and their families in effective OAA-SM, and improve patients' quality of life and care.
Authors: Sandra L Spoelstra; Barbara A Given; Charles W Given; Marcia Grant; Alla Sikorskii; Mei You; Veronica Decker Journal: Clin J Oncol Nurs Date: 2013-12 Impact factor: 1.027
Authors: Sandra L Spoelstra; Charles W Given; Alla Sikorskii; Constantinos K Coursaris; Atreyee Majumder; Tracy DeKoekkoek; Monica Schueller; Barbara A Given Journal: J Adv Nurs Date: 2015-06-23 Impact factor: 3.187
Authors: Christel C L M Boons; Lonneke Timmers; Natasja M van Schoor; Eleonora L Swart; N Harry Hendrikse; Jeroen J W M Janssen; Jacqueline G Hugtenburg Journal: Cancer Med Date: 2017-11-23 Impact factor: 4.452
Authors: Yun Jiang; Karen E Wickersham; Xingyu Zhang; Debra L Barton; Karen B Farris; John C Krauss; Marcelline R Harris Journal: Patient Prefer Adherence Date: 2019-12-31 Impact factor: 2.711
Authors: Stacy Cooper Bailey; Izabela E Annis; Daniel S Reuland; Autumn D Locklear; Betsy L Sleath; Michael S Wolf Journal: Patient Prefer Adherence Date: 2015-07-31 Impact factor: 2.711